SCHEMBL6671344

SCHEMBL6671344

COc1ccc2[nH]cc(C(=O)Nc3ccccn3)c2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.54
RAB9A P51151 6/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
TP53 P04637 1/20 0.54
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
F2 P00734 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
FGFR3 P22607 1/20 0.46
KDM4E B2RXH2 1/20 0.46
RXFP1 Q9HBX9 1/20 0.45
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
HTR1A P08908 2/20 0.44
HTR1B P28222 2/20 0.44
HTR1F P30939 2/20 0.44
GRM5 P41594 2/20 0.44
HTR1D P28221 1/20 0.44
CHRNB2 P17787 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6722139 0.89 RXFP1 (0.54) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6726671 0.84 PIM1 (0.43) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6302311 0.84 NPC1 (0.47) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6722035 0.84 HTR2C (0.44) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6727000 0.84 RXFP1 (0.44) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6722073 0.84 NPC1 (0.42) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6726254 0.84 NPC1 (0.42) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6726282 0.83 MEN1 (0.55) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL6724813 0.83 HTR1A (0.55) HTR1AHTR1BHTR1FGRM5HTR1D
SCHEMBL6728799 0.83 NPC1 (0.41) NPC1RAB9AMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453831-A1 1H-PYRROLO(3,2-B)PYRIDINE-3-CARBOXYLIC ACID AMIDES Neurogen Corporation (US) 2004-09-08 EP claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
WO-2003044018-A1 1H-PYRROLO[3,2-B]PYRIDINE-3-CARBOXYLIC ACID AMIDES NEUROGEN CORPORATION (US) 2003-05-30 WO claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed